Skip to main content

Theravance Biopharma, Inc.

TBPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001583107

In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Theravance Biopharma, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
116
−2 vs. Q3 2021
Shares held
59.3M
−1.22M (−2.0%) vs. Q3 2021
Total value
$655.6M
+$207.5M (+46.3%) vs. Q3 2021
New holders
21
50 more added
Sold out
23
28 more reduced

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TBPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 116 institutions
Q1 2021: 107 institutionsQ2 2021: 109 institutionsQ3 2021: 119 institutionsQ4 2021: 116 institutionsQ1 2022: 121 institutionsQ2 2022: 113 institutionsQ3 2022: 123 institutionsQ4 2022: 119 institutionsQ1 2023: 114 institutionsQ2 2023: 119 institutionsQ3 2023: 115 institutionsQ4 2023: 118 institutionsQ1 2024: 121 institutionsQ2 2024: 132 institutionsQ3 2024: 119 institutionsQ4 2024: 128 institutionsQ1 2025: 132 institutionsQ2 2025: 135 institutionsQ3 2025: 161 institutionsQ4 2025: 169 institutionsQ1 2026: 173 institutionsQ2 2026: 179 institutions
Value heldQ4 2021: $655.6M
Q1 2021: $1.09BQ2 2021: $883.1MQ3 2021: $448.8MQ4 2021: $655.6MQ1 2022: $602.5MQ2 2022: $582.0MQ3 2022: $649.8MQ4 2022: $696.1MQ1 2023: $652.6MQ2 2023: $546.3MQ3 2023: $438.5MQ4 2023: $548.7MQ1 2024: $430.6MQ2 2024: $399.5MQ3 2024: $368.9MQ4 2024: $422.4MQ1 2025: $400.9MQ2 2025: $512.2MQ3 2025: $706.3MQ4 2025: $927.2MQ1 2026: $814.2MQ2 2026: $817.5M
Institutions holding TBPH and their total value by quarter
QuarterHoldersValue
Q2 2026179$817.5M
Q1 2026173$814.2M
Q4 2025169$927.2M
Q3 2025161$706.3M
Q2 2025135$512.2M
Q1 2025132$400.9M
Q4 2024128$422.4M
Q3 2024119$368.9M
Q2 2024132$399.5M
Q1 2024121$430.6M
Q4 2023118$548.7M
Q3 2023115$438.5M
Q2 2023119$546.3M
Q1 2023114$652.6M
Q4 2022119$696.1M
Q3 2022123$649.8M
Q2 2022113$582.0M
Q1 2022121$602.5M
Q4 2021116$655.6M
Q3 2021119$448.8M
Q2 2021109$883.1M
Q1 2021107$1.09B

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Theravance Biopharma, Inc.; share changes are against Q3 2021.

Institutions holding TBPH in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Parallel Advisors, LLC1,899$21.0K0.00%+994+109.8%Added
Tower Research Capital LLC (TRC)1,749$19.0K0.00%−1,760−50.2%Reduced
Allworth Financial LP1,130$12.0K0.00%+1,130New
TCI Wealth Advisors, Inc.515$6.00K0.00%+515New
Rockefeller Capital Management L.P.625$6.00K0.00%+625New
Captrust Financial Advisors369$4.00K0.00%+369New
Whittier Trust Co289$3.00K0.00%00.0%Unchanged
Signaturefd, LLC309$3.00K0.00%+154+99.4%Added
Daiwa Securities Group Inc.215$2.00K0.00%+95+79.2%Added
Advisor Group Holdings, Inc.138$2.00K0.00%00.0%Unchanged
Quadrant Capital Group LLC174$2.00K0.00%+137+370.3%Added
Private Capital Group, LLC136$2.00K0.00%+136New
Pacific Center for Financial Services57$1.00K0.00%00.0%Unchanged
The PNC Financial Services Group, Inc.88$00.00%00.0%Unchanged
Ellevest, Inc.37$00.00%+18+94.7%Added
Plante Moran Financial Advisors, LLC20$00.00%+20New
Rock Springs Capital Management LP0$00.00%−687,500−100.0%Sold out
Clearline Capital LP0$00.00%−577,800−100.0%Sold out
Tri Locum Partners LP0$00.00%−129,192−100.0%Sold out
Pura Vida Investments, LLC0$00.00%−100,000−100.0%Sold out
Hennion & Walsh Asset Management, Inc.0$00.00%−62,546−100.0%Sold out
Blueshift Asset Management, LLC0$00.00%−53,127−100.0%Sold out
Davenport & Co LLC0$00.00%−34,000−100.0%Sold out
Campbell & CO Investment Adviser LLC0$00.00%−27,200−100.0%Sold out
Laurion Capital Management LP0$00.00%−27,095−100.0%Sold out
Principal Financial Group Inc0$00.00%−24,799−100.0%Sold out
Occudo Quantitative Strategies LP0$00.00%−23,958−100.0%Sold out
Palisade Capital Management LLC0$00.00%−22,000−100.0%Sold out
Engineers Gate Manager LP0$00.00%−18,482−100.0%Sold out
Diversified Trust Co0$00.00%−14,721−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−14,791−100.0%Sold out
Handelsbanken Fonder AB0$00.00%−13,516−100.0%Sold out
Rafferty Asset Management, LLC0$00.00%−12,649−100.0%Sold out
Nisa Investment Advisors, LLC0$00.00%−7,000−100.0%Sold out
Penserra Capital Management LLC0$00.00%−1,685−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−775−100.0%Sold out
Nomura Holdings Inc0$00.00%−352−100.0%Sold out
Massmutual Trust Co FSB0$00.00%−39−100.0%Sold out
Kowal Investment Group, LLC0$00.00%−20−100.0%Sold out
Zazove Associates LLC––––Not filed